Associations between circulating immunologic markers and HCC in individuals with chronic HCV infection.

S Sonal Kale (National Cancer Institute, National Institutes of Health, Bethesda, MD) I Ilona Argirion T Thomas Oâ€Brien (National Cancer Institute, National Institutes of Health, Bethesda, MD) A Allan Hildesheim Z Zhiwei Liu R Ruth Pfeiffer A Anna Lok (University of Michigan, Ann Arbor, MI) T Timothy Morgan M Mei-Hsuan Lee (National Yang Ming Chiao Tung University, Taipei, Taiwan) J Jill Koshiol

Abstract

e16271 Background: Although immunologic proteins have been associated with hepatocellular carcinoma (HCC) development, little is known about whether these associations are with HCC or underlying fibrosis/cirrhosis. Methods: We sampled 92 HCC cases and 184 controls from The Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) prospective study. All participants were chronically infected with hepatitis C virus (HCV) and presented with advanced fibrosis or cirrhosis. Conditional logistic regression was used to compare baseline plasma levels for 248 markers in individuals who developed HCC vs. controls. We also evaluated the association between immune markers and cirrhosis (Ishak 5-6) vs. fibrosis (Ishak 3-4) among controls. We assessed biological pathways associated with HCC development compared to controls. P-values for individual markers and pathways were corrected for multiple testing; p-value < 0.05 was used to determine significance among a-priori markers. Results: After multivariable adjustment, three a-priori markers: ICAM-1 (Q 4v1 OR: 8.1; 95%CI: 2.8-23.4), HGF (Q 4v1 OR: 3.1; 95%CI: 1.2-8.0), SCF (Q 4v1 OR: 0.4; 95%CI: 0.2-0.9) and seven novel markers: ACE2 (Q 4v1 OR: 5.2; 95%CI: 1.8-15.2), CDH1 (Q 4v1 OR: 3.2; 95%CI: 1.3-7.5), CD244 (Q 4v1 OR: 4.6; 95%CI: 1.8-12.0), OPG (Q 4v1 OR: 6.1; 95%CI: 2.1-17.4), TNFRSF10A (Q 4v1 OR: 3.3; 95%CI: 1.4-8.1), NOTCH1 (Q 4v1 OR: 2.8; 95%CI: 1.2-6.5), and HAOX1 (Q 4v1 OR: 3.4; 95%CI: 1.3-8.7) were significantly associated with HCC development. All three a-priori markers, as well as ACE2, CDH1, and CD244, were shown to be significantly associated with cirrhosis vs. fibrosis. Biological pathways related to apoptotic process, cellular response to cytokine stimulus, extracellular matrix organization and inflammatory response were associated with HCC development. Conclusions: We confirmed the association of ICAM-1, HGF, and SCF and identified 7 additional proteins associated with HCV-related HCC in the context of underlying fibrosis/cirrhosis.

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (10)

S

Sonal Kale

National Cancer Institute, National Institutes of Health, Bethesda, MD

I

Ilona Argirion

T

Thomas Oâ€Brien

National Cancer Institute, National Institutes of Health, Bethesda, MD

A

Allan Hildesheim

Z

Zhiwei Liu

R

Ruth Pfeiffer

A

Anna Lok

University of Michigan, Ann Arbor, MI

T

Timothy Morgan

M

Mei-Hsuan Lee

National Yang Ming Chiao Tung University, Taipei, Taiwan

J

Jill Koshiol